SV
Sravanthi Vankudoth
About Sravanthi Vankudoth
Data last updated:
Sravanthi Vankudoth is a Director at Apicem Pharmaceuticals Private Limited (since 2020) and Director at Newloris Pharmaceuticals Private Limited (since 2025). The companies operate in Chemicals and Pharma. The largest current company by reported revenue is Apicem Pharmaceuticals Private Limited at ₹29 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apicem Pharmaceuticals Private Limited U24100KA2020PTC191552 | Director | 02 Nov 2020 | 2020 | ₹29 Lakh (FY 2024) | Active |
| Newloris Pharmaceuticals Private Limited U47721TS2024PTC192485 | Director | 23 Apr 2025 | 2024 | Active |
Board colleagues of Sravanthi Vankudoth
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gopal Naik Vankadothu | 10650014 | Apicem Pharmaceuticals Private Limited , Newloris Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sravanthi Vankudoth
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sravanthi Vankudoth
Sravanthi Vankudoth currently holds 2 directorships: Apicem Pharmaceuticals Private Limited (Director, since 02 Nov 2020, revenue ₹29 Lakh (FY 2024)); Newloris Pharmaceuticals Private Limited (Director, since 23 Apr 2025).
Sravanthi Vankudoth was first appointed on 02 Nov 2020 as Director at Apicem Pharmaceuticals Private Limited. The most recent appointment on record is 23 Apr 2025 at Newloris Pharmaceuticals Private Limited.
The current boards of Sravanthi Vankudoth's companies include Gopal Naik Vankadothu (Apicem Pharmaceuticals Private Limited).